Loading…
Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway
Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to preve...
Saved in:
Published in: | Drug design, development and therapy development and therapy, 2023-11, Vol.17, p.3363-3383 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3 |
container_end_page | 3383 |
container_issue | |
container_start_page | 3363 |
container_title | Drug design, development and therapy |
container_volume | 17 |
creator | Jin, Xiaoming He, Riming Lin, Yunxin Liu, Jiahui Wang, Yuzhi Li, Zhongtang Liao, Yijiao Yang, Shudong |
description | Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p |
doi_str_mv | 10.2147/DDDT.S433994 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_77bd4e3e976f46999ddcd2b0de827321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A778571124</galeid><doaj_id>oai_doaj_org_article_77bd4e3e976f46999ddcd2b0de827321</doaj_id><sourcerecordid>A778571124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3</originalsourceid><addsrcrecordid>eNptkkGL2zAQhU1podttb_0BhkLpoUkkWbasY0i62dCULmQLvYmxNIoVHCsryZT8-zqbpexCmcMMj-89GHhZ9pGSKaNczJbL5f10y4tCSv4qu6JUiEld1_T1s_tt9i7GPSFVUTFylT1sW-xjO4CzQ74K0A8d5vOUsB8gYcznekiYf3emx1O-7vdDOOXN-Wpd45Lrd_kNhuCPyUcX8x9o3GgzZ-RYFrPtZiHmlM5Wd795fgep_QOn99kbC13ED0_7Ovt18-1-cTvZ_FytF_PNRHMm0kSXhHFqqGR1RRsEKq0Fo4nlwKCwoGVZldCYklDC0FpJCeUABakoI9Y2xXW2vuQaD3t1DO4A4aQ8OPUo-LBTEJLTHSohGsOxQCkqyysppTHasIYYrJkoGB2zvlyyjsE_DBiTOrioseugRz9ExWpZCiJKwUb00wXdwZjseutTAH3G1VyIuhSUMj5S0_9Q4xg8OO17tG7UXxg-PzO0CF1qo--G5HwfX4JfL6AOPsaA9t_rlKhzS9S5JeqpJcVfcVGsmw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2895707572</pqid></control><display><type>article</type><title>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</title><source>Taylor & Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jin, Xiaoming ; He, Riming ; Lin, Yunxin ; Liu, Jiahui ; Wang, Yuzhi ; Li, Zhongtang ; Liao, Yijiao ; Yang, Shudong</creator><creatorcontrib>Jin, Xiaoming ; He, Riming ; Lin, Yunxin ; Liu, Jiahui ; Wang, Yuzhi ; Li, Zhongtang ; Liao, Yijiao ; Yang, Shudong</creatorcontrib><description><![CDATA[Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p<0.01) and BUN (p<0.0001) levels, pathological damage (p<0.0001), dead cells in the tubular epithelium (p<0.0001) and iron deposition (p<0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p<0.01), the expressions of high mobility group box 1 (UMGB1, p<0.05) and interleukin (IL)-17 (p<0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p<0.01), and catalase (CAT, p<0.05), and alleviated mitochondrial dysfunction (p<0.05). More importantly, SSF regulated iron transport and intracellular iron overload and reduced the expression of ferritin (p<0.05). Moreover, it downregulated the expressions of cyclo-oxygenase-2 (Cox-2, p<0.001), acid CoA ligase 4 (ACSL4, p<0.05), and solute carrier family 7, member 11 (SLC7A11, p<001), upregulated glutathione peroxidase 4 (GPX4, p<0.01) and p53 (p<0.01), and decreased 4-hydroxynonenal (4-HNE) level (p<0.001). Conclusion: SSF attenuates AKI by inhibiting ferroptosis mediated by p53/SLC7A11/GPX4 pathway. Keywords: acute kidney injury, cisplatin, ferroptosis, shenshuaifu granule, p53/SLC7A11/GPX4 pathway]]></description><identifier>ISSN: 1177-8881</identifier><identifier>EISSN: 1177-8881</identifier><identifier>DOI: 10.2147/DDDT.S433994</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>acute kidney injury ; Cell death ; cisplatin ; Ferritin ; ferroptosis ; High performance liquid chromatography ; Inflammation ; p53/slc7a11/gpx4 pathway ; shenshuaifu granule ; Superoxide ; Tumor proteins ; Urea</subject><ispartof>Drug design, development and therapy, 2023-11, Vol.17, p.3363-3383</ispartof><rights>COPYRIGHT 2023 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924,37012</link.rule.ids></links><search><creatorcontrib>Jin, Xiaoming</creatorcontrib><creatorcontrib>He, Riming</creatorcontrib><creatorcontrib>Lin, Yunxin</creatorcontrib><creatorcontrib>Liu, Jiahui</creatorcontrib><creatorcontrib>Wang, Yuzhi</creatorcontrib><creatorcontrib>Li, Zhongtang</creatorcontrib><creatorcontrib>Liao, Yijiao</creatorcontrib><creatorcontrib>Yang, Shudong</creatorcontrib><title>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</title><title>Drug design, development and therapy</title><description><![CDATA[Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p<0.01) and BUN (p<0.0001) levels, pathological damage (p<0.0001), dead cells in the tubular epithelium (p<0.0001) and iron deposition (p<0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p<0.01), the expressions of high mobility group box 1 (UMGB1, p<0.05) and interleukin (IL)-17 (p<0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p<0.01), and catalase (CAT, p<0.05), and alleviated mitochondrial dysfunction (p<0.05). More importantly, SSF regulated iron transport and intracellular iron overload and reduced the expression of ferritin (p<0.05). Moreover, it downregulated the expressions of cyclo-oxygenase-2 (Cox-2, p<0.001), acid CoA ligase 4 (ACSL4, p<0.05), and solute carrier family 7, member 11 (SLC7A11, p<001), upregulated glutathione peroxidase 4 (GPX4, p<0.01) and p53 (p<0.01), and decreased 4-hydroxynonenal (4-HNE) level (p<0.001). Conclusion: SSF attenuates AKI by inhibiting ferroptosis mediated by p53/SLC7A11/GPX4 pathway. Keywords: acute kidney injury, cisplatin, ferroptosis, shenshuaifu granule, p53/SLC7A11/GPX4 pathway]]></description><subject>acute kidney injury</subject><subject>Cell death</subject><subject>cisplatin</subject><subject>Ferritin</subject><subject>ferroptosis</subject><subject>High performance liquid chromatography</subject><subject>Inflammation</subject><subject>p53/slc7a11/gpx4 pathway</subject><subject>shenshuaifu granule</subject><subject>Superoxide</subject><subject>Tumor proteins</subject><subject>Urea</subject><issn>1177-8881</issn><issn>1177-8881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkkGL2zAQhU1podttb_0BhkLpoUkkWbasY0i62dCULmQLvYmxNIoVHCsryZT8-zqbpexCmcMMj-89GHhZ9pGSKaNczJbL5f10y4tCSv4qu6JUiEld1_T1s_tt9i7GPSFVUTFylT1sW-xjO4CzQ74K0A8d5vOUsB8gYcznekiYf3emx1O-7vdDOOXN-Wpd45Lrd_kNhuCPyUcX8x9o3GgzZ-RYFrPtZiHmlM5Wd795fgep_QOn99kbC13ED0_7Ovt18-1-cTvZ_FytF_PNRHMm0kSXhHFqqGR1RRsEKq0Fo4nlwKCwoGVZldCYklDC0FpJCeUABakoI9Y2xXW2vuQaD3t1DO4A4aQ8OPUo-LBTEJLTHSohGsOxQCkqyysppTHasIYYrJkoGB2zvlyyjsE_DBiTOrioseugRz9ExWpZCiJKwUb00wXdwZjseutTAH3G1VyIuhSUMj5S0_9Q4xg8OO17tG7UXxg-PzO0CF1qo--G5HwfX4JfL6AOPsaA9t_rlKhzS9S5JeqpJcVfcVGsmw</recordid><startdate>20231130</startdate><enddate>20231130</enddate><creator>Jin, Xiaoming</creator><creator>He, Riming</creator><creator>Lin, Yunxin</creator><creator>Liu, Jiahui</creator><creator>Wang, Yuzhi</creator><creator>Li, Zhongtang</creator><creator>Liao, Yijiao</creator><creator>Yang, Shudong</creator><general>Dove Medical Press Limited</general><general>Dove Medical Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20231130</creationdate><title>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</title><author>Jin, Xiaoming ; He, Riming ; Lin, Yunxin ; Liu, Jiahui ; Wang, Yuzhi ; Li, Zhongtang ; Liao, Yijiao ; Yang, Shudong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>acute kidney injury</topic><topic>Cell death</topic><topic>cisplatin</topic><topic>Ferritin</topic><topic>ferroptosis</topic><topic>High performance liquid chromatography</topic><topic>Inflammation</topic><topic>p53/slc7a11/gpx4 pathway</topic><topic>shenshuaifu granule</topic><topic>Superoxide</topic><topic>Tumor proteins</topic><topic>Urea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jin, Xiaoming</creatorcontrib><creatorcontrib>He, Riming</creatorcontrib><creatorcontrib>Lin, Yunxin</creatorcontrib><creatorcontrib>Liu, Jiahui</creatorcontrib><creatorcontrib>Wang, Yuzhi</creatorcontrib><creatorcontrib>Li, Zhongtang</creatorcontrib><creatorcontrib>Liao, Yijiao</creatorcontrib><creatorcontrib>Yang, Shudong</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Drug design, development and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Xiaoming</au><au>He, Riming</au><au>Lin, Yunxin</au><au>Liu, Jiahui</au><au>Wang, Yuzhi</au><au>Li, Zhongtang</au><au>Liao, Yijiao</au><au>Yang, Shudong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</atitle><jtitle>Drug design, development and therapy</jtitle><date>2023-11-30</date><risdate>2023</risdate><volume>17</volume><spage>3363</spage><epage>3383</epage><pages>3363-3383</pages><issn>1177-8881</issn><eissn>1177-8881</eissn><abstract><![CDATA[Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p<0.01) and BUN (p<0.0001) levels, pathological damage (p<0.0001), dead cells in the tubular epithelium (p<0.0001) and iron deposition (p<0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p<0.01), the expressions of high mobility group box 1 (UMGB1, p<0.05) and interleukin (IL)-17 (p<0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p<0.01), and catalase (CAT, p<0.05), and alleviated mitochondrial dysfunction (p<0.05). More importantly, SSF regulated iron transport and intracellular iron overload and reduced the expression of ferritin (p<0.05). Moreover, it downregulated the expressions of cyclo-oxygenase-2 (Cox-2, p<0.001), acid CoA ligase 4 (ACSL4, p<0.05), and solute carrier family 7, member 11 (SLC7A11, p<001), upregulated glutathione peroxidase 4 (GPX4, p<0.01) and p53 (p<0.01), and decreased 4-hydroxynonenal (4-HNE) level (p<0.001). Conclusion: SSF attenuates AKI by inhibiting ferroptosis mediated by p53/SLC7A11/GPX4 pathway. Keywords: acute kidney injury, cisplatin, ferroptosis, shenshuaifu granule, p53/SLC7A11/GPX4 pathway]]></abstract><pub>Dove Medical Press Limited</pub><doi>10.2147/DDDT.S433994</doi><tpages>21</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1177-8881 |
ispartof | Drug design, development and therapy, 2023-11, Vol.17, p.3363-3383 |
issn | 1177-8881 1177-8881 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_77bd4e3e976f46999ddcd2b0de827321 |
source | Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central |
subjects | acute kidney injury Cell death cisplatin Ferritin ferroptosis High performance liquid chromatography Inflammation p53/slc7a11/gpx4 pathway shenshuaifu granule Superoxide Tumor proteins Urea |
title | Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T00%3A53%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Shenshuaifu%20Granule%20Attenuates%20Acute%20Kidney%20Injury%20by%20Inhibiting%20Ferroptosis%20Mediated%20by%20p53/SLC7A11/GPX4%20Pathway&rft.jtitle=Drug%20design,%20development%20and%20therapy&rft.au=Jin,%20Xiaoming&rft.date=2023-11-30&rft.volume=17&rft.spage=3363&rft.epage=3383&rft.pages=3363-3383&rft.issn=1177-8881&rft.eissn=1177-8881&rft_id=info:doi/10.2147/DDDT.S433994&rft_dat=%3Cgale_doaj_%3EA778571124%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2895707572&rft_id=info:pmid/&rft_galeid=A778571124&rfr_iscdi=true |